India’s Serum applies to conduct local trial for Novavax vaccine: CEO ...United Arab Emirates

Gulf News - News
India’s Serum applies to conduct local trial for Novavax vaccine: CEO
New Delhi: The Serum Institute of India (SII), the world’s biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc’s COVID-19 vaccine, which was found to be 89.3% effective in a UK trial. Serum expected a decision on an Indian trial of Novavax’s vaccine soon, Chief Executive Adar Poonawalla told Reuters on Friday, hours after the US company reported the efficacy data. “We have already applied to the drug controller’s office for the bridging trial, a few days ago,” Poonawalla said. “So they should also give that approval soon now.” Novavax’s UK trial, which enrolled 15,000 people aged 18 to 84, is expected to be used to apply for use in Britai

Hence then, the article about india s serum applies to conduct local trial for novavax vaccine ceo was published today ( ) and is available on Gulf News ( United Arab Emirates ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( India’s Serum applies to conduct local trial for Novavax vaccine: CEO )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News